Repression of the IgH enhancer in teratocarcinoma cells associated with a novel octamer factor.
暂无分享,去创建一个
L. Staudt | D. Baltimore | P. Robbins | R. Mulligan | M. Lenardo | A. Kuang | P. Robbins
[1] F. Fujimura,et al. Unique requirement for the PyF441 mutation for polyomavirus infection of F9 embryonal carcinoma cells , 1988, Journal of virology.
[2] P. Sharp,et al. Cloning of a lymphoid-specific cDNA encoding a protein binding the regulatory octamer DNA motif. , 1988, Science.
[3] J. Perez-Mutul,et al. Mutational analysis of the contribution of sequence motifs within the IgH enhancer to tissue specific transcriptional activation , 1988, Nucleic Acids Res..
[4] L. Su,et al. Identification and characterization of two functional domains within the murine heavy-chain enhancer , 1988, Molecular and cellular biology.
[5] N. Heintz,et al. Purification and characterization of OTF-1, a transcription factor regulating cell cycle expression of a human histone H2b gene , 1987, Cell.
[6] A. Heguy,et al. Identification and purification of a human lymphoid-specific octamer-binding protein (OTF-2) that activates transcription of an immunoglobulin promoter in vitro , 1987, Cell.
[7] L. Staudt,et al. An octamer oligonucleotide upstream of a TATA motif is sufficient for lymphoid-specific promoter activity , 1987, Nature.
[8] G. Superti-Furga,et al. Mutually exclusive interaction of the CCAAT-binding factor and of a displacement protein with overlapping sequences of a histone gene promoter , 1987, Cell.
[9] J. Nevins,et al. A factor discriminating between the wildtype and a mutant polyomavirus enhancer , 1987, Nature.
[10] D. Baltimore,et al. Protein-binding sites in Ig gene enhancers determine transcriptional activity and inducibility. , 1987, Science.
[11] K. Yamamoto,et al. The immunoglobulin octanucleotide: independent activity and selective interaction with enhancers. , 1987, Science.
[12] W. Schaffner,et al. The SV40 enhancer can be dissected into multiple segments, each with a different cell type specificity. , 1987, Genes & development.
[13] A. Bothwell,et al. Mutational analysis of the immunoglobulin heavy chain promoter region. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[14] P. Sharp,et al. A lymphoid-specific protein binding to the octamer motif of immunoglobulin genes , 1986, Nature.
[15] P. Tucker,et al. Interaction of cell-type-specific nuclear proteins with immunoglobulin VH promoter region sequences , 1986, Nature.
[16] P. Chambon,et al. Cell-type specific protein binding to the enhancer of simian virus 40 in nuclear extracts , 1986, Nature.
[17] T. Kadesch,et al. Functional analysis of the murine IgH enhancer: evidence for negative control of cell-type specificity. , 1986, Nucleic acids research.
[18] R. Roeder,et al. Interaction of a common factor with conserved promoter and enhancer sequences in histone H2B, immunoglobulin, and U2 small nuclear RNA (snRNA) genes. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[19] P. Chambon,et al. A mutated polyoma virus enhancer which is active in undifferentiated embryonal carcinoma cells is not repressed by adenovirus-2 E1A products , 1986, Nature.
[20] P. Sharp,et al. A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes , 1986, Nature.
[21] P. Rigby,et al. Negative regulation of viral enhancers in undifferentiated embryonic stem cells , 1985, Cell.
[22] T. Vogt,et al. Tissue-specific activation of a cloned α-fetoprotein gene during differentiation of a transfected embryonal carcinoma cell line , 1984, Nature.
[23] P Berg,et al. Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. , 1982, Journal of molecular and applied genetics.
[24] S. Strickland,et al. Hormonal induction of differentiation in teratocarcinoma stem cells: Generation of parietal endoderm by retinoic acid and dibutyryl cAMP , 1980, Cell.
[25] S. Strickland,et al. The induction of differentiation in teratocarcinoma stem cells by retinoic acid , 1978, Cell.
[26] G. Martin,et al. Teratocarcinomas as a model system for the study of embryogenesis and neoplasia , 1975, Cell.